A Real Options Game of Alliance Timing Decisions in Biopharmaceutical Researh and Development. Morreale, A., Robba, S., Nigro, G.L., and Roma, P. Documento de Trabajo, Universidad Complutense de Madrid, pp.
La Valoración de un Proyecto de Inversión Biotecnológico como una Opción Real Compuesta. The Value of an Option to Exchange One Asset for Another. Valuing American Options by Simulation: A Simple Least-Squares Approach. Valuation of Biotechnology Companies: Real Options Approach under Uncertainty. Ljumovic, I., Cvijanovic, J.M., and Lazi, J. Valuation of a Biotech Company: A Real Options Approach. Valuation Techniques: discounted cash flow, erning quality measures of added value and real options. Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease? PLoS Negl Trop Dis 11(2): e0005361. , Johansen, K.H., Engmark, M., and Andersen, M. Intellectual Property Challenges for the Modern Biotechnology Enerprise.Mikolais Romris University, Finland. Valuation of a Biotechnological Firm: An Application of Real Options Methodologies. Real Options Valuation or a Biotech Company. the Use of Valuation Models by European Biotehcnology Analyst. The Business Model of SMEs Biotech: How Do Biotech SMEs cope with the Industry’s Challenges.Masters Theses. Modeling sequential R&D investments: a binomial compound option approach. Returns on R&D for 1990s New Drug Introductions. Grabowski, H., Vernon, J., and Di Masi, J.A. Global Journal of Flexible Management Systems 14, pp. Real Options Analysis on Strategic Partnership Dealing of Biotech Satrt-ups. Journal of Finance and Accounting, vol3,num 2, pp. Blending Scenarios into Real Options: Relevance of the Pay-off to Management Investment Decisions. DOI: 10-2225/Vol15-issue 3.įavato, G., Cottingham J.A., and Isachencova, N. an Economic Valuation of a Biotechnology R&D Project in a Developing Economy. Pharfmaceutical Industry in Mexico: 2016 Perspectives.DuTilly Consultors.Įrbas, B.C., and Memis, S.A. International Journal of Management Reviews, vol. Real Options in management and Organizational strategy: A review of Decision Making and Performance Implications. The Cost of Biopharmaceutical R&D: Is Biotech Different? Managerial and Decision Economics, vol. Influence Diagrams for Real Options Valuation, Journal of Finance Case Research 9, No. Master Hedmark University College.ĭemirer, R., J. Human Capital n Life Science Firm Valuation: A Theoretical Model. Deloitte Touche Tohmatsu, UK.ĭevkota, H.K. World Scientific Publishingĭeloitte (2017). Measuring and Managing the Value of Companies. Journal of Commercial Biotechnology, vol10, num.4, pp. The Class of 2014: Human Capital in Biotechnology. International Journal of Industrial and System Technology, vol.10, num.
A framework for applying real options analysis to information technology investments. W-N., Chenng, C.H., Gunasekaran, A., and Wong, K.F. Incorporating Technical Risk in Compound Real Option Models to Value a Pharmaceutical R&D Licensing Opportunity. 41-51.Ĭassimon, D., DeBacker, M., Engelen, P-J., Van Wouve, M., and Yordanov, V. The Valuation of a NDA using a 6-Fold Compund Option. 1235-1256.Ĭassimon, D., Engelen, P.J., Thomassen, L, and Van Wouve, L. The Valuation of Sequential Exchange Opportunities. Real Option Approach to R&D Project Valuation: Case Study at Serono International S.A. The Price of Options and Corporate Liabilities. Journal of Finance 42, pp.301-320.īerk, J., and DeMarzo, P. Efficient Analytic Approximation of American Option Values. Novosibirsk State Technical University Publ., Monograph, 272 9.īarone-Adesi and Whaley, R. (2013) The Evaluation of the Effectiveness of Venture Capital Financing of Innovative Projects by Real Options Method, Novosibirsk Monograph. Valuation of Compound Real Options for Investments in Innovative Lecture Notes in Economics and Mathematical Systems, vol 587.īaranov, A.O., and and Musyko E. an Option-Based View of Imperfect Patent Protection.
0 kommentar(er)
